BINYAMINA, Israel, June 16, 2021 /PRNewswire/ — OncoHost, global leader in host response profiling for improved personalized cancer therapy, today announced a collaboration with the United Kingdom National Health Service (NHS), launching eight clinical trial sites in the UK. These trials will provide proteomic analysis for patients diagnosed with advanced stages of melanoma or non-small cell lung cancer (NSCLC) receiving immunotherapy, to help predict their response to treatment.
Read more here.
Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://blog.ourcrowd.com/nhs-opens-eight-uk-clinical-trial-sites-to-assess-cancer-patient-response-to-immunotherapy-in-collaboration-with-oncohost/
